FDA Cleared for Diagnostic, Blood Donor Screening and Cadaveric (Non-heart beating) Tissue Screening
The ASI Evolution® can process and analyze up to 190 samples per hour. One technician can easily run three ASI Evolutions simultaneously, with the ability to perform over 4,000 tests in an eight-hour shift.
The ASI Evolution reduces the amount of hands on time required to run an RPR test, freeing up valuable lab resources.
“The CDC continues to recommend the traditional screening algorithm using a nontreponemal test (e.g., RPR or VDRL), with reactive nontreponemal tests confirmed by treponemal testing.”*
A 2015 CDC study determined that nontreponemal tests can detect infection up to 14 days earlier than treponemal tests.
The ASI Evolution® is the world’s first and only fully-automated system for nontreponemal RPR Syphilis testing for diagnostic, blood donor and cadaveric tissue screening. Simply load your reagents and samples, then walk-away. The Evolution automates the processing, analysis, reporting and archival of results for RPR screens.